Y-mAbs Therapeutics rakes in $30 mln

Y-mAbs Therapeutics Inc, a New York City and Denmark-based developer of cancer treatments, has raised $30 million in a private placement. The investors were Sofinnova Ventures and Scopia Capital Management.

North AmericaUSBriefs